SCHEMBL1759102

SCHEMBL1759102

CCCCCC(=O)OCC1CC1

nearest known ligand 0.57

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.57
LPAR1 Q92633 2/20 0.52
LPAR3 Q9UBY5 2/20 0.52
PAM P19021 2/20 0.52
NAAA Q02083 2/20 0.51
ENPP2 Q13822 2/20 0.51
LMNA P02545 1/20 0.49
TSHR P16473 1/20 0.49
MAPT P10636 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11756487 0.98 DGKA (0.60) DGKALPAR1LPAR3PAMNAAA
SCHEMBL11751466 0.98 DGKA (0.60) DGKALPAR1LPAR3PAMNAAA
SCHEMBL29379735 0.98 DGKA (0.60) DGKALPAR1LPAR3PAMNAAA
SCHEMBL1759070 0.98 DGKA (0.60) DGKALPAR1LPAR3PAMNAAA
SCHEMBL1759077 0.98 DGKA (0.60) DGKALPAR1LPAR3PAMNAAA
SCHEMBL11755305 0.98 DGKA (0.60) DGKALPAR1LPAR3PAMNAAA
SCHEMBL11749335 0.98 DGKA (0.60) DGKALPAR1LPAR3PAMNAAA
SCHEMBL30581340 0.94 LMNA (0.50) DGKALPAR1LPAR3PAMNAAA
SCHEMBL31032397 0.91 DGKA (0.56) DGKALPAR1LPAR3PAMNAAA
SCHEMBL1291727 0.91 NAAA (0.60) DGKALPAR1LPAR3PAMNAAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102596890-B Esters as perfuming ingredients FIRMENICH & CIE 2014-12-17 CN claimed
US-8871967-B2 Esters as perfuming ingredients FIRMENICH SA (CH) 2014-10-28 US claimed
EP-2496548-B1 Esters as perfuming ingredients FIRMENICH & CIE (CH) 2013-08-28 EP claimed
EP-2496548-A1 ESTERS AS PERFUMING INGREDIENTS Firmenich S.A. (CH) 2012-09-12 EP claimed
US-20120195844-A1 ESTERS AS PERFUMING INGREDIENTS FIRMENICH SA (CH) 2012-08-02 US claimed
CN-102596890-A Esters as perfuming ingredients FIRMENICH & CIE 2012-07-18 CN claimed
WO-2011055251-A1 ESTERS AS PERFUMING INGREDIENTS FIRMENICH SA (CH) 2011-05-12 WO claimed
CN-102596890-B Esters as perfuming ingredients FIRMENICH & CIE 2014-12-17 CN disclosed
US-8871967-B2 Esters as perfuming ingredients FIRMENICH SA (CH) 2014-10-28 US disclosed
US-8871967-B2 Esters as perfuming ingredients FIRMENICH SA (CH) 2014-10-28 US disclosed
US-8871967-B2 Esters as perfuming ingredients FIRMENICH SA (CH) 2014-10-28 US disclosed
EP-2496548-B1 Esters as perfuming ingredients FIRMENICH & CIE (CH) 2013-08-28 EP disclosed
EP-2496548-B1 Esters as perfuming ingredients FIRMENICH & CIE (CH) 2013-08-28 EP disclosed
EP-2496548-A1 ESTERS AS PERFUMING INGREDIENTS Firmenich S.A. (CH) 2012-09-12 EP disclosed
US-20120195844-A1 ESTERS AS PERFUMING INGREDIENTS FIRMENICH SA (CH) 2012-08-02 US disclosed
US-20120195844-A1 ESTERS AS PERFUMING INGREDIENTS FIRMENICH SA (CH) 2012-08-02 US disclosed
US-20120195844-A1 ESTERS AS PERFUMING INGREDIENTS FIRMENICH SA (CH) 2012-08-02 US disclosed
CN-102596890-A Esters as perfuming ingredients FIRMENICH & CIE 2012-07-18 CN disclosed
WO-2011055251-A1 ESTERS AS PERFUMING INGREDIENTS FIRMENICH SA (CH) 2011-05-12 WO disclosed
US-3975429-A Cyclopropanemethyl esters of cinnamic acid and derivatives thereof ZOECON CORPORATION (US) 1976-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120195844-A1 ESTERS AS PERFUMING INGREDIENTS C5, CBR3, C1S DGKA 2453/4885LPAR1 3049/4885LPAR3 1777/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.